Stepping into the headquarters of IGC Pharma, one is immediately struck by the company’s dedication to innovation. The air is heavy with a sense of progress and

On May 14, Prof Govindaraju received the Government of India-instituted National Technology Award for “outstanding contribution in commercialising innovative indigenous technologies” from the Minister of State for Science and Technology and Earth Sciences, Dr Jitendra Singh.

Hamsa Biopharma, which will take the drug — Christened TGR63 — to trials through its parent company in the US, IGC Pharma, hopes it can eventually be made available in the market.

Researchers in India say they have discovered a promising drug target that may slow or even halt the progression of Alzheimer’s.